Proper Pressure and Duration of Sustained Lung Inflation in Preterm Infants

April 1, 2018 updated by: Nehad Nasef, Mansoura University Children Hospital

Sustained Lung Inflation at Birth for Preterm Infants at Risk of Respiratory Distress Syndrome: the Proper Pressure and Duration: Prospective Randomized Study

The appropriate pressure and duration needed for sustained lung inflation in preterm infants at risk of respiratory distress syndrome have not been well evaluated. We aim for evaluating two different pressures, 20 and 15 cm H2O, for two different duration, 10 and 20 seconds, during the application of sustained lung inflation in the resuscitation of preterm infants with respiratory distress in the delivery room.

Study Overview

Detailed Description

This study will be a randomized prospective pilot study in Mansoura University Hospital then the cases were followed at Neonatal Intensive Care Unit in Mansoura University Children Hospital, Mansoura, Egypt.

Preterm infants born equal to or less than 32 weeks gestation with respiratory distress syndrome will be included in the study.

We aim to study the proper pressure and duration of sustained lung inflation in the delivery room.

Preterm infants will be divided into 5 groups:

  1. Group 1 (Control group). In this group preterm infants will not be treated with sustained lung inflation and in stead will receive regular respiratory care
  2. Group 2 (High pressure for long duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 20 cm H2O for 20 seconds
  3. Group 3 (High pressure for short duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 20 cm H2O for 10 seconds.
  4. Group 4 (Low pressure for long duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 15 cm H2O for 20 seconds.
  5. Group 5 (Low pressure for short duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 15 cm H2O for 10 seconds

Sustained lung inflation will be delivered using the T - piece ventilator (Neopuff infant resuscitator; Fisher & Paykel, Auckland, New Zealand ).

All preterm infants with respiratory distress will follow the following steps for neonatal resuscitation

  1. All infants will receive initial care including providing warmth, clearing the airway, and drying and stimulating the infant.
  2. After the initial steps, pulse oximetry will be initiated to determine oxygen saturation and to guide the required FIO2.
  3. Infants in the intervention groups will receive a single single maneuver of sustained lung inflation with the first breath according to the study group.
  4. Continuous positive airway pressure at a pressure of 5 cm H2O and FIO2 of 30% will be delivered to infants in the control group immediately after initial steps of resuscitation and to all infants in the intervention groups after the single maneuver of sustained lung inflation.
  5. Positive pressure ventilation will be provided uring the T-piece resuscitator if the infant has an inadequate respiratory effort or a heart rate <100 beats per minute at a rate of 40 to 60 times per minute for 30 seconds, after which the heart rate is measured.
  6. Oxygen therapy will be titrated to keep a pre-ductal saturation between 90-95%.
  7. Endotracheal intubation will be provided if positive pressure ventilation is ineffective, prolonged apnea, or chest compression is required.
  8. Chest compression will be required if the infant's heart rate remains <60 bpm despite adequate ventilation for 30 seconds.
  9. Surfactant will be administered to preterm infants requiring a fraction of inspired oxygen of 40 percent or higher to maintain oxygen saturation above 90 percent or remain apneic.
  10. Mechanical ventilation will be initiated for preterm infants with respiratory acidosis documented by an arterial pH <7.2 and PaCO2 >60 to 65 mmHg, hypoxia documented by an arterial PaO2 <50 mmHg despite FiO2 exceeds 40 percent on nasal continuous positive airway pressure, or severe apnea.

The primary outcome of the study will be the need for endotracheal intubation in the delivery room.

Secondary outcomes include the need for surfactant therapy, the need for endotracheal intubation and mechanical ventilation within 72 hours of birth, the duration of mechanical ventilation and oxygen support, development of air leak syndromes, length of hospital stay, bronchopulmonary dysplasia, necrotising enterocolitis, intraventricular haemorrhage, retinopathy of prematurity, and neonatal mortality before hospital discharge,.

Broncho alveolar lavage will be performed to endotracheally intubated infants enrolled in this study to measure the level of IL-10 as a lung inflammatory marker immediately after birth (basal) then 12 hours after birth (follow up).

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • El Dakahlya
      • Mansoura, El Dakahlya, Egypt, 35111
        • Mansoura University Children Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 3 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Preterm infants with gestational age ≤ 32 weeks' gestation, presented with respiratory distress syndrome at birth

Exclusion Criteria:

  1. - Preterm infants with no manifestations of respiratory distress syndrome at birth.
  2. - Presence of major congenital malformation (dysmorphic features or anomalies incompatible with life) .

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Infants in this group will not receive sustained lung inflation in the delivery room and will be put immediately on CPAP at a pressure of 5 cm H2O.
Active Comparator: High pressure for long duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 20 cm H2O for a duration of 20 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
Active Comparator: High pressure for short duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 20 cm H2O for a duration of 10 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
Active Comparator: Low pressure for long duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 15 cm H2O for a duration of 20 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
Active Comparator: Low pressure for short duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 15 cm H2O for a duration of 10 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The need for endotracheal intubation in the delivery room
Time Frame: One hour
One hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The need for mechanical ventilation
Time Frame: 72 hours
72 hours
Need of surfactant
Time Frame: 72 hours
72 hours
Neonatal mortality
Time Frame: 90 days
Death before hospital discharge
90 days
Broncho Pulmonary Dysplasia ( BPD )
Time Frame: 90 days
Requirement for oxygen therapy more than 30% by 36 weeks corrected gestational age
90 days
Intra-Ventricular Hemorrhage ( IVH )
Time Frame: 14 days
14 days
Retinopathy of Prematurity ( ROP )
Time Frame: 50 days
50 days
Necrotizing Entero Colitis ( NEC )
Time Frame: 40 days
40 days
Length of neonatal intensive care ( NICU ) and hospital stay
Time Frame: 90 days
90 days
Air-leak syndrome
Time Frame: 14 days
Development of pneumothorax or pneumomediastinum
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

July 22, 2016

First Submitted That Met QC Criteria

July 22, 2016

First Posted (Estimate)

July 27, 2016

Study Record Updates

Last Update Posted (Actual)

April 3, 2018

Last Update Submitted That Met QC Criteria

April 1, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Distress Syndrome

Clinical Trials on Sustained lung inflation in preterms (SLI).

Subscribe